JP2012501318A5 - - Google Patents

Download PDF

Info

Publication number
JP2012501318A5
JP2012501318A5 JP2011524451A JP2011524451A JP2012501318A5 JP 2012501318 A5 JP2012501318 A5 JP 2012501318A5 JP 2011524451 A JP2011524451 A JP 2011524451A JP 2011524451 A JP2011524451 A JP 2011524451A JP 2012501318 A5 JP2012501318 A5 JP 2012501318A5
Authority
JP
Japan
Prior art keywords
binding moiety
eoc
ovarian cancer
protein
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011524451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012501318A (ja
Filing date
Publication date
Priority claimed from GBGB0815846.1A external-priority patent/GB0815846D0/en
Application filed filed Critical
Publication of JP2012501318A publication Critical patent/JP2012501318A/ja
Publication of JP2012501318A5 publication Critical patent/JP2012501318A5/ja
Pending legal-status Critical Current

Links

JP2011524451A 2008-09-01 2009-09-01 上皮性卵巣癌の診断又は予後診断方法 Pending JP2012501318A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0815846.1 2008-09-01
GBGB0815846.1A GB0815846D0 (en) 2008-09-01 2008-09-01 diagnosis, prognosis and imaging of disease
PCT/GB2009/002098 WO2010023458A1 (en) 2008-09-01 2009-09-01 Method of diagnosing or prognosing epithelial ovarian cancer

Publications (2)

Publication Number Publication Date
JP2012501318A JP2012501318A (ja) 2012-01-19
JP2012501318A5 true JP2012501318A5 (enExample) 2012-10-18

Family

ID=39866018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011524451A Pending JP2012501318A (ja) 2008-09-01 2009-09-01 上皮性卵巣癌の診断又は予後診断方法

Country Status (7)

Country Link
US (4) US20110217238A1 (enExample)
EP (1) EP2329042B1 (enExample)
JP (1) JP2012501318A (enExample)
CN (1) CN102186994A (enExample)
ES (1) ES2605254T3 (enExample)
GB (1) GB0815846D0 (enExample)
WO (1) WO2010023458A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
GB0910620D0 (en) * 2009-06-19 2009-08-05 Immunovia Ab Agents and uses thereof
WO2013013117A1 (en) 2011-07-20 2013-01-24 Mikroscan Technologies, Inc. Network-based pathology system with desktop slide scanner
US20150284783A1 (en) * 2012-05-21 2015-10-08 Agena Bioscience, Inc. Methods and compositions for analyzing nucleic acid
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
AU2014348371B2 (en) 2013-11-15 2019-11-07 Mikroscan Technologies, Inc. Geological scanner
US10162166B2 (en) 2014-10-28 2018-12-25 Mikroscan Technologies, Inc. Microdissection viewing system
US20170097355A1 (en) * 2015-10-06 2017-04-06 University Of Washington Biomarkers and methods to distinguish ovarian cancer from benign tumors
CN108085392A (zh) * 2018-01-09 2018-05-29 山大生殖研发中心有限公司 上皮性卵巢癌的生物标志物及其用途
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237770A1 (en) * 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2005002417A2 (en) * 2003-06-20 2005-01-13 Avalon Pharmaceuticals, Inc. Cancer -linked gene aas target for chemotherapy
BRPI0412110A (pt) * 2003-07-02 2006-11-21 Novartis Ag genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos
EP1806413A1 (en) * 2006-01-06 2007-07-11 Oligene GmbH An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer

Similar Documents

Publication Publication Date Title
JP2012501318A5 (enExample)
JP2009540803A5 (enExample)
Lee et al. Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC)
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2014108048A (ru) Способ обнаружения рака поджелудочной железы
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2014508298A5 (enExample)
US20190033316A1 (en) Methods and kits for the diagnosis of cancer
IL192866A (en) Detecting cancer with high levels of 2 bcl
JP2010513901A5 (enExample)
CA2792163A1 (en) Biomarkers of osteoarthritis
US10724097B2 (en) Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
JP2011516038A5 (enExample)
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
JP2010207229A5 (enExample)
JP2011517937A5 (enExample)
ES2861440T5 (en) Use of nucleosome-transcription factor complexes for cancer detection
ES2551713T3 (es) Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal
CN103487588B (zh) Galectin-4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用
JP2011516037A5 (enExample)
Kamal et al. Current biomarkers of IgA nephropathy
Tok et al. Simple workflow to repurpose SARS-CoV-2 swab/serum samples for the isolation of cost-effective antibody/antigens for proteotyping applications and diagnosis
JP6066220B2 (ja) ＩｇＡ凝集体の検出方法およびＩｇＡ腎症の検査方法
US20230133776A1 (en) Methods for diagnosing cancer
JP2011513759A5 (enExample)